8. References

1. Alegre-Díaz, Herrington, López-Cervantes et al. Diabetes and cause-specific mortality in Mexico City.
New Engl J Med 2016; 375: 1961-1971.

2. Herrington, Alegre-Díaz, Wade et al. Effect of diabetes duration and glycaemic control on 14-year
cause-specific mortality in Mexican adults: a blood-based prospective cohort study. Lancet Diab Endocrinol 2018; 6: 455-463.

3. Bragg, Kuri-Morales, Berumen et al. Diabetes and infectious disease mortality in Mexico City
BMJ Open Diab Res Care 2023;11:e003199.

4. Gnatiuc, Alegre-Díaz, Wade et al. General and abdominal adiposity and mortality in Mexico City:
prospective study of 150 000 adults. Ann Int Med 2019; 171: 397-405

5. Gnatiuc, Tapia-Conyer, Wade et al. Abdominal and gluteo-femoral markers of adiposity and risk of
vascular-metabolic mortality in a prospective study of 150 000 Mexican adults. Eur J Prev Cardiol 2022:29(5);730-8.

6. Alegre-Díaz, Friedrichs, Ramirez-Reyes et al. Body mass index and COVID-19 mortality: prospective
study of 120 000 Mexican adults. Int J Epidemiol. 2022;51(5):1698-700.

7. Gnatiuc Friedrichs, Wade, Alegre-Díaz etal. Body Composition and Risk of Vascular-Metabolic
Mortality Risk in 113 000 Mexican Men and Women Without Prior Chronic Disease. J Am Heart Assoc. 2023 Jan 25:e028263.

8. Tapia-Conyer, Alegre-Díaz, Gnatiuc et al. Association of blood pressure with cause-specific mortality
in Mexican adults. JAMA Network Open. 2020; 3: e201814.

9. Thomson, Tapia-Conyer, Lacey et al. Low-intensity daily smoking and cause-specific mortality in
Mexico: prospective study of 150,000 adults. Int J Epidemiol 2021; 50: 955-964.

10. Addey T, Alegre-Díaz J, Bragg F et al. Educational and social inequalities and cause-specific mortality
in Mexico City: a prospective study. Lancet Public Health 2023; 8(9): e670-e679

11. Kuri-Morales, Emberson, Alegre Díaz et al. The prevalence of chronic diseases and major disease
risk factors at different ages among 150 000 men and women living in Mexico City: cross-sectional analyses of a prospective study. BMC Public Health 2009, 9:9.

12. Aguilar-Ramirez, Alegre-Díaz, Gnatiuc et al. Changes in the diagnosis and management of diabetes
in Mexico City between 1998-2004 and 2015-19. Diabetes Care 2021;44(4):944-51

13. Gnatiuc, Alegre-Díaz, Halsey et al. Adiposity and Blood Pressure in 110 000 Mexican Adults.
Hypertension 2017; 69: 608-614.

14. González-Carballo, Kuri-Morales, Chiquete, et al. Cognitive impairment at older ages among 8000
men and women living in Mexico City: cross-sectional analyses of a prospective study. medRxiv 2024.04.25.24306237.

15. Aguilar-Ramirez, Alegre-Díaz, Herrington et al. Association of kidney function with NMR-quantified
lipids, lipoproteins, and metabolic measures in Mexican adults. J Clin Endocrinol Metab 2021; 106(10): 2828-2839.

16. Aguilar-Ramirez, Herrington, Alegre-Díaz et al. Adiposity and NMR-measure lipid and metabolic
biomarkers among 30,000 Mexican adults. Commun Med 2022; 2:143.